Click here to view next page of this article
Pediatric and Adolescent AIDS
Worldwide, WHO estimates 1.1 million children
living with HIV
590,000 newly infected children in 2006
In US, HIV linked to rapidly growing HIV
problem in women
In US, estimated 12,240 children living with HIT in early 1994
90% of cases due to perinatal transmission in
1995
Greatest number of children in Southeast, NY/NJ/DC, Puerto Rico
Epidemiology in children in the future
will reflect overlap of two trends- Epidemiology of HIV in women
and the
epidemiology of good prenatal health care which can prevent much of HIV infection
Impact of ACTG 076 already evident. Pediatric AIDS rates falling nationwide, but implementation is inconsistent. In the US, AIDS in children is theoretically eradicable.
Adolescents and HIV - rapidly
increasing but a talk for another day...
Perinatal transmission
Overall transmission rate 14%-39%. Closer
to 25-27% in developed countries. Recent understanding of timing
of transmission has improved
In utero (30-50% of transmission)
Working definition: Evidence of virus by culture/l:'CR at birth (by day 7)
Peripartum (50-75% of transmission)
Working definition: negative virus culture/PCR at birth, + after day 7
Breast Feeding
Risk clearly confirmed, magnitude
modest (7-22%) but inexact
Prevention
Drug therapy - AZT
ACTG 076: AZT po beginning after wk 12, IV during delivery and po for baby 6 weeks after reduced risk by
Nucleoside Reverse Transcriptase Inhibitors )(NNRTIs)
Oidanoslne
(dideoxyinosine) (ddt), VIDEX
Preparations: Pediatric powder for oral solution (when reconstituted as
Lamlvudlne
(3TC), EPIVIR
Preparations:
Solution: l0 mg/mL; Tablets: 150 mg
Zalcitabine (ddC), HIVID
Zidovudlne (ZDV, AZT), RETROVIR
Efavirenz (EFV), SUSTIVA
Indlnavlr,
CRIXIVAN
Preparations:
Capsules' 200 and 400 mg
Nelfinavir, VIRACEPT
Rltonovlr,
NORVIR
Saquinavir,
INVIRASETM TM (hard gel capsule) and FORTOVASETM